MoneyMan
14 years ago
Conmed Healthcare Management, Inc. Reports Record Revenues for Fourth Quarter and Full Year 2009
Conmed Healthcare Management, Inc. (NYSE Amex: CONM), a leading full service provider of correctional facility healthcare services to county and municipal detention centers, today announced financial results for its fourth quarter and year ended December 31, 2009.
Fourth Quarter Financial Highlights
Net revenue increased 14.9% to $14.0 million from $12.2 million in last year's comparable period. Gross profit increased 12.3% to $2.7 million (19.2% gross margin), compared to $2.4 million (19.7% gross margin) last year. Operating expenses as a percentage of revenue declined 330 basis points to 16.3% from 19.6% in the year-ago period. Operating income was approximately $0.4 million, compared to approximately $11,000 in the fourth quarter of 2008. Net income of approximately $1.4 million, or $0.11 per basic share and $0.07 per diluted share, compared to net income of approximately $19,000, or $0.00 per basic and diluted share, in last year’s same period. The Company generated approximately $940,000 in positive cash flow in the fourth quarter, with $11.1 million in cash and cash equivalents as of December 31, 2009.
Fourth Quarter Highlights:
Pima County, Arizona agreed to extend its contract with Conmed for healthcare services at the Pima County Adult Detention Center for two years, covering the period from July 1, 2010 through June 30, 2012. This remains Conmed’s largest contract to date and is expected to generate approximately $19.5 million in revenues throughout the term of the contract, or $9.7 million per year for each of the two year periods. Baltimore County, Maryland exercised the first of two three-year extension periods for Conmed to provide services for the Baltimore County Detention Center. The contract is valued at almost $6.0 million per annum and is Conmed’s second largest contract. Sedgwick County, Kansas, one of Conmed’s top three customers, agreed to a new five-year contract with Conmed for the adult detention facility. The value of this contract totals approximately $22.2 million.
Subsequent to Year-End:
Signed a new 29-month contract with Pima County, Arizona to provide services at their Juvenile Detention Center with projected revenues of approximately $2.8 million. Agreement provides for two additional one-year extension periods available at the county’s option. Signed agreement with Clark County, Washington, a new customer, to provide medical services for individuals detained at three county facilities. The contract is projected to generate approximately $16.0 million throughout the full six-year term. Signed agreement with Garrett County, Maryland, with extensions expected to generate revenues of approximately $1.0 million over the full four and one-half year term.
Fourth Quarter Financial Results
Net revenue for the three months ended December 31, 2009 increased $1.8 million, or 14.9%, to $14.0 million from $12.2 million in last year's comparable period. The revenue improvement resulted from the addition of contracts signed with new jurisdictions since September 30, 2008. Revenues also increased as a result of the acquisition of Correctional Mental Health Services, LLC (“CMHS”) on November 4, 2008, as well as the expansion of services under existing contracts and price increases related to existing services.
"The fourth quarter of 2009 demonstrated continued solid momentum in our financial performance and the consistent execution of our growth strategy,” commented Richard Turner, Chairman and Chief Executive Officer of Conmed. “We again achieved record revenues in the fourth quarter and full year 2009, increased our operating income, increased our cash generation and generated a solid, debt free balance sheet. The results continue to demonstrate the leverage in our operating model as we believe that our business has scaled to the point where our expanded client base and our recurring revenue model are more directly impacting the bottom line. We maintained our existing business, expanded geographically, improved our pricing, expanded services in many existing accounts and were awarded renewals with several of our largest current customers. Even though our rate of growth slowed in the fourth quarter, bid activity remains strong and we made three announcements of new multi-year contracts subsequent to the year-end that position us well for 2010 and beyond.”
Total healthcare expenses for the quarter ended December 31, 2009 were $11.3 million compared to $9.8 million in the year-ago period. The increase primarily reflects increased healthcare and mental health staffing plus medical and operating expenses required to support new business. Gross profit increased 12.3% to $2.7 million from $2.4 million in the prior year period, while gross margin declined slightly from 19.7% to 19.2%.
Total operating expenses decreased 4.0% to $2.3 million for the quarter ended December 31, 2009 compared to $2.4 million for the year-ago period. Operating expenses as a percentage of revenue declined 330 basis points to 16.3% from 19.6% in the year-ago period, which continues to reflect the leverage in the Company’s operating model. Selling, general and administrative expenses for the fourth quarter were $1.9 million, or 13.9% of revenue, compared to $1.8 million, or 14.6% of revenue, for the year-ago quarter. The slight increase reflects investments in additional management and administrative personnel required to support the new contracts and services added in 2008, as well as to sustain the Company during anticipated future growth. Depreciation and amortization decreased 43% for the quarter to $343,000 from $599,000 in the year ago period. The decrease primarily reflects a reduction in amortization expense related to acquired contracts that have become fully amortized.
Conmed reported record operating income of approximately $400,000 in the fourth quarter up approximately 35-fold compared to operating income of approximately $11,000 in the fourth quarter last year. Net income was $1.4 million, or $0.11 per basic share and $0.07 per diluted share, compared to net income of approximately $19,000, or $0.00 per basic and diluted share, in the year-ago period. The fourth quarter 2009 net income included a $479,000 adjustment to reflect the change in fair value of derivatives (outstanding warrants) as required under EITF 07-5** plus a one-time tax benefit of $709,000 related to the reversal of the deferred tax valuation reserve.
Dr. Turner concluded, “During 2009, we observed that many county and municipal governments were struggling with budget pressures as they tried to maintain service levels with less revenue, even as inmate populations expanded. We believe that Conmed was able to demonstrate the additional value that our services provide by performing more efficiently than the county and municipal governments could themselves, all the while improving or maintaining quality of service. We continue to strengthen our brand and our unique service proposition, which includes our quality of service, our audit compliance track record and our exceptional customer renewal and retention rates. Our remarkable record of customer retention over the last 25 years truly sets us apart. We believe our quality record is one very important reason our clients choose us and stay with us over the long run.”
For the fourth quarter of 2009, adjusted EBITDA*, a non-GAAP measure, grew 17.8% to approximately $896,000 compared to approximately $761,000 in the prior year’s fourth quarter.
Year-to-Date Results
Net revenue for the year ended December 31, 2009 increased $12.2 million to a record $52.8 million, up 30.2%, compared to a record $40.6 million for last year's comparable period. Approximately $10.8 million, or 88.6%, of the year-over-year increase is due to the addition of new medical service contracts acquired after December 31, 2007. Revenue improvement related to the expansion of the services provided under a number of our existing contracts as well as price increases related to existing service requirements totaled approximately $1.7 million, or 14.1%, of the increase.
Total healthcare expenses for the year ended December 31, 2009 were $42.1 million compared to $33.1 million in the year-ago period. For the full year, gross profit increased 44% to $10.7 million, representing 20.3% gross margin, compared to gross profit of $7.4 million, or 18.3%, gross margin in last year's same period.
Total operating expenses were $9.7 million, or 18.4% of revenue, for the year ended December 31, 2009 compared to $8.5 million, or 20.9% of revenue, for the year-ago period. Conmed's operating income was approximately $998,000 compared to an operating loss of ($1.1 million) in the same period last year. The net loss for the year ended December 31, 2009 was approximately ($27,000), or ($0.00) loss per basic and diluted share (based on approximately 12.6 million weighted average shares outstanding), compared to a loss of ($919,000), or ($0.08) loss per basic and diluted share (based on approximately 12.1 million weighted average shares outstanding), in the year ago period. The full year 2009 net loss included a $1.2 million non-cash charge for a change in fair value of derivative instruments (outstanding warrants) as required under EITF 07-5**.
For the full year 2009, adjusted EBITDA* increased 119% to approximately $3.6 million compared to approximately $1.6 million in last year’s same period.
The Company generated approximately $3.6 million in operating cash flow in the year ended December 31, 2009, and had $11.1 million in cash and cash equivalents as of December 31, 2009 compared to $7.5 million at December 31, 2008. Shareholders’ equity increased to $15.5 million at December 31, 2009 compared to $14.9 million at December 31, 2008. Days Sales Outstanding (DSO) as of December 31, 2009 was approximately 16 days. The Company paid down the approximately $205,000 of its remaining debt during 2009, and currently is debt-free.
*Use of Non-GAAP Measures
In addition to containing results that are determined in accordance with accounting principles generally accepted in the United States of America (GAAP), this press release also contains non-GAAP financial measures. Adjusted EBITDA, as used in this press release, represents net income (loss) from continuing operations before interest, taxes, depreciation and amortization adjusted for stock-based compensation, change in fair value of derivative financial instruments and gains or losses on the sale of assets. Adjusted EBITDA is a key indicator used by management to evaluate operating performance. While adjusted EBITDA is not intended to replace any presentation included in the consolidated financial statements under GAAP and should not be considered an alternative to operating performance or an alternative to cash flow as a measure of liquidity, the Company believes this measure is useful to investors in assessing the Company’s capital expenditures and working capital requirements. This calculation may differ in method of calculation from similarly titled measures used by other companies. A reconciliation of adjusted EBITDA to the nearest comparable GAAP financial measure is included in the financial schedules accompanying this press release. The adjusted financial measure, as well as other information in this press release, should be read in conjunction with the Company’s financial statements filed with the Securities and Exchange Commission.
**EITF 07-5 -- Determining Whether an Instrument (or Embedded Feature) Is Indexed to an Entity’s Own Stock:
We are required to record a non-cash charge to our GAAP results per Emerging Issues Task Force (“EITF”) Issue No. 07-5, Determining Whether an Instrument (or Embedded Feature) Is Indexed to an Entity’s Own Stock and thus our financial statements will continue to include this charge going forward until certain events occur and/or conditions are met, as defined in the new regulations. As a result of the Company’s adoption of EITF 07-5 effective January 1, 2009, approximately 1.7 million of our issued and outstanding common stock purchase warrants previously treated as equity pursuant to the derivative treatment exemption were no longer afforded equity treatment and as a result they are now being recorded as a liability based on fair value estimates. These common stock purchase warrants do not trade in an active securities market, and as such, we estimate the fair value of these warrants using the Black-Scholes option pricing model and all changes in the fair value of these warrants will be recognized currently in earnings until such time as the warrants are exercised, amended or expire.
Conference Call
Conmed will host a conference call today, Thursday, March 25, 2010, at 4:30 PM ET. Anyone interested in participating should call 877-941-2069 if calling within the United States or 480-629-9713 if calling internationally. A re-play will be available until April 1, 2010 which can be accessed by dialing 800-406-7325 if calling within the United States or 303-590-3030 if calling internationally. Please use passcode 4269918 to access the replay.
The call will also be accompanied by a live webcast over the Internet and accessible at Conmed’s corporate website at www.conmedinc.com or directly at http://viavid.net/dce.aspx?sid=00007276.
About Conmed
Conmed has provided correctional healthcare services since 1984, beginning in the State of Maryland, and currently serves county and municipal correctional facilities in thirty-eight counties in seven states, including Arizona, Kansas, Maryland, Oklahoma, Oregon, Virginia and Washington. Conmed's services have expanded to include mental health, pharmacy and out-of-facility healthcare services.
di4
15 years ago
Conmed Healthcare Management, Inc. Reports Record Financial Results for First Quarter 2009
First Quarter Revenue Increases 58% to $12.4 Million
May 14, 2009 4:05:00 PM
Copyright Business Wire 2009
Email Story Discuss on ZenoBank
View Additional ProfilesHANOVER, Md.--(BUSINESS WIRE)-- Conmed Healthcare Management, Inc. (OTCBB:CMHM), a leading full service provider of correctional facility healthcare services to county and municipal adult and juvenile detention centers, today announced financial results for its first quarter ended March 31, 2009.
First Quarter Financial Highlights
-- Net revenue increased 58% to $12.4 million from $7.8 million in last
year's comparable period.
-- Gross profit increased 81% to $2.7 million (21.5% gross margin),
compared to $1.5 million (18.8% gross margin) last year.
-- Operating expenses as a percentage of sales were 19.7% compared to 26.7%
in the year-ago period, reflecting improved operating leverage.
-- Net income of approximately $118,000 marks third consecutive quarter of
profitability and a $670,000 swing from a loss of approximately $
(552,000) in the year-ago period.
-- The Company generated approximately $951,000 in positive cash flow in
the first quarter, and finished the quarter with $8.3 million in cash
and cash equivalents, or $0.61 per diluted share, as of March 31, 2009.
Operating Highlights
-- The November 2008 acquisition of Correctional Mental Health Services,
LLC ("CMHS") has resulted in the expansion of services where Conmed is
already providing general healthcare services.
-- Announced new contract with the Western Virginia Regional Jail in Salem,
Virginia for medical services, expected to generate $1.7 million per
year in revenue, effective February 1, 2009.
First Quarter Results
Net revenue for the three months ended March 31, 2009 increased $4.6 million, or 58%, to $12.4 million from $7.8 million in last year's comparable period. The revenue improvement was derived from several sources, including the addition in 2008 of new medical service contracts, the contracts acquired from both Emergency Medicine Documentation Consultants P.C. in February 2008 and the CMHS acquisition in November 2008 plus the expansion of services and price adjustments on contracts with several counties which were already customers of Conmed.
"Our record financial performance in the first quarter of 2009 reflects extraordinary growth across the board, from revenue through profitability," commented Richard Turner, Chairman and Chief Executive Officer of Conmed Healthcare Management. "We maintained the pace of rapid growth that we achieved throughout 2008."
Dr. Turner continued, "We are proud to report that the first quarter of 2009 was our third consecutive quarter of profitability. We believe that our expanding client base and highly-recurring revenue base combined with the operating leverage in our financial model is resulting in rapid growth at the bottom line. In addition, our operating expenses decreased as a percentage of revenues to 19.7% compared to 26.7% in the year-ago period, which reflects a 700 basis point decrease and demonstrates substantial improvement in operating leverage. The addition of behavioral health services as a result of our CMHS acquisition has allowed us to expand our national behavioral healthcare services and has already generated add-on business. We expect this synergy to continue to contribute to our top- and bottom-lines going forward and expect to continue to pursue a variety of options, including additional acquisitions, to fuel future growth."
Total healthcare expenses for the period ended March 31, 2009 were $9.8 million compared to $6.4 million in the year-ago period. The increase reflects increased staffing and medical services to support new business resulting primarily from the increase in medical service contracts. Gross profit for the first quarter of 2009 was up 81% to $2.7 million, representing a 21.5% gross margin, compared to $1.5 million and 18.8%, respectively, in last year's same period.
Total operating expenses were $2.5 million for the quarter ended March 31, 2009 compared to $2.1 million for the year-ago period. Operating expenses as a percentage of sales were 19.7% compared to 26.7% in the year-ago period. Selling, general and administrative expenses for the first quarter were $1.8 million or 14.6% of revenue compared to $1.6 million or 20.3% of revenue for the year-ago quarter, and reflects investments in additional management and administrative personnel required to support the new contracts and services added in 2008, as well as to sustain the Company during anticipated future growth.
Conmed reported operating income of approximately $215,000 in the first quarter compared to an operating loss of approximately $(616,000) in the first quarter last year. Net income was approximately $118,000 or $0.01 per basic and fully diluted share compared to a loss of approximately $(552,000) last year, or $(0.05) per basic and fully diluted share.
For the first quarter of 2009, adjusted EBITDA, a non-GAAP measure, grew to approximately $1.0 million compared to approximately $3,000 in the prior year first quarter.
The Company generated approximately $951,000 in operating cash flow in the quarter ended March 31, 2009, and had $8.3 million in cash and cash equivalents as of March 31, 2009 compared to $7.5 million at December 31, 2008. Shareholders' equity decreased to $12.5 million at March 31, 2009 compared to $14.9 million at December 31, 2008.
Use of Non-GAAP Measures
In addition to containing results that are determined in accordance with accounting principles generally accepted in the United States of America (GAAP), this press release also contains the Company's "EBITDA" results, which are non-GAAP earnings results that exclude certain items. Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) and adjusted EBITDA are key indicators used by management to evaluate operating performance. While EBITDA and adjusted EBITDA are not intended to replace any presentation included in the consolidated financial statements under GAAP and should not be considered an alternative to operating performance or an alternative to cash flow as a measure of liquidity, the Company believes this measure is useful to investors in assessing its capital expenditures and working capital requirements. This calculation may differ in method of calculation from similarly titled measures used by other companies. Adjusted EBITDA, as used in the press release, represents income from continuing operations before interest, taxes, depreciation and amortization adjusted for stock-based compensation, gains or losses on the sale of assets, impairment charges, change in fair value of derivative financial instruments and other unusual or non-recurring transactional events. A reconciliation of EBITDA and adjusted EBITDA to the nearest comparable GAAP financial measures is included in the financial schedules accompanying this press release. The adjusted financial measures, as well as other information in this press release, should be read in conjunction with the Company's financial statements filed with the Securities and Exchange Commission.
Conference Call
Conmed will host a conference call today, Thursday, May 14, at 4:30 PM ET. Anyone interested in participating should call 877-941-9205 if calling within the United States or 480-629-9835 if calling internationally. A re-play will be available until May 21, 2009, which can be accessed by dialing 800-406-7325 if calling within the United States or 303-590-3030 if calling internationally. Please use passcode 4070894 to access the replay.
The webcast will also be broadcast live over the internet and accessible at http://viavid.net/dce.aspx?sid=000063D1, and archived for 30 days.
About Conmed
Conmed has provided correctional healthcare services since 1984, beginning in the State of Maryland, and currently services detention centers and correctional facilities in thirty-three counties in six states, including Washington, Arizona, Kansas, Maryland, Oregon and Virginia. Conmed's services have expanded to include mental health, pharmacy and out-of-facility healthcare services.
Forward Looking Statements
This press release may contain, among other things, certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, (i) statements with respect to the Company's plans, objectives, expectations and intentions; and (ii) other statements that are not historical facts including statements which may be identified by words such as "may", "could", "would", "should", "believes", "expects", "anticipates", "estimates", "intends", "plans", "projects", "potentially" or similar expressions. These statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. These forward-looking statements involve certain risks and uncertainties that are subject to change based on various factors (many of which are beyond the Company's control) including, without limitation, the Company's ability to increase revenue and to continue to obtain new contracts, contract renewals and extensions; the ability to obtain bonds; decreases in occupancy levels or disturbances at detention centers; malpractice litigation; the ability to utilize third party administrators for out-of-facility care; compliance with laws and government regulations, including those relating to healthcare; competition; termination of contracts due to lack of government appropriations; material adverse changes in economic and industry conditions in the healthcare market; negative publicity regarding the provision of correctional healthcare services; dependence on key personnel and the ability to hire skilled personnel; increases in healthcare costs; insurance; completion and integration of future acquisitions; public company obligations; and stock price volatility. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K filed with the SEC for the fiscal year ended December 31, 2008. Investors and security holders are urged to read this document free of charge on the SEC's web site at www.sec.gov. The Company does not undertake to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
CONMED HEALTHCARE MANAGEMENT,
INC.
CONSOLIDATED BALANCE SHEETS
March 31, 2009 (unaudited) December 31,
2008
ASSETS
CURRENT ASSETS
Cash and cash equivalents $ 8,285,126 $ 7,472,140
Accounts receivable 2,925,592 2,375,583
Prepaid expenses 139,021 291,599
Total current assets 11,349,739 10,139,322
PROPERTY AND EQUIPMENT, NET 511,296 529,304
DEFERRED TAXES 645,000 645,000
OTHER ASSETS
Service contracts acquired, net 1,510,000 2,004,000
Non-compete agreements, net 724,667 821,667
Goodwill 6,254,544 6,254,544
Deposits 15,408 15,408
Total other assets 8,504,619 9,095,619
$ 21,010,654 $ 20,409,245
LIABILITIES AND SHAREHOLDERS'
EQUITY
CURRENT LIABILITIES
Accounts payable $ 1,353,204 $ 1,080,259
Accrued expenses 3,549,171 3,210,749
Taxes payable 179,283 432,380
Deferred revenue 640,295 561,734
Notes payable, current portion 52,213 170,228
Total current liabilities 5,774,166 5,455,350
NOTES PAYABLE, LONG-TERM 35,000 35,000
DERIVATIVE FINANCIAL INSTRUMENTS 2,726,360 --
SHAREHOLDERS' EQUITY
Preferred stock no par value;
authorized 5,000,000 shares;
issued and outstanding zero -- --
shares as of March 31, 2009 and
December 31, 2008
Common stock, $0.0001 par value,
authorized 40,000,000 shares;
issued and outstanding 12,477,539 1,248 1,246
and 12,457,539 shares as of March
31, 2009 and December 31, 2008,
respectively
Additional paid-in capital 34,680,263 36,875,610
Retained (deficit) (22,206,383 ) (21,957,961 )
Total shareholders' equity 12,475,128 14,918,895
$ 21,010,654 $ 20,409,245
CONMED HEALTHCARE MANAGEMENT, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
For the Three For the Three
Months Ended Months Ended
March 31, 2009 March 31, 2008
Service contract revenue $ 12,419,241 $ 7,836,250
HEALTHCARE EXPENSES:
Salaries, wages and employee benefits 6,987,854 4,114,027
Medical expenses 2,381,933 2,016,588
Other operating expenses 384,205 233,436
Total healthcare expenses 9,753,992 6,364,051
Gross profit $ 2,665,249 $ 1,472,199
Selling and administrative expenses 1,815,527 1,589,012
Depreciation and amortization 634,821 499,450
Total operating expenses 2,450,348 2,088,462
Operating income (loss) 214,901 (616,263 )
OTHER INCOME (EXPENSE)
Interest income 28,628 65,898
Interest (expense) (5,205 ) (1,689 )
Change in fair value of derivatives 866 --
Total other income 24,289 64,209
Income (loss) before income taxes 239,190 (552,054 )
Income tax (expense) (121,000 ) --
Net income (loss) $ 118,190 $ (552,054 )
LOSS PER COMMON SHARE
Basic $ 0.01 $ (0.05 )
Diluted $ 0.01 $ (0.05 )
WEIGHTED-AVERAGE SHARES OUTSTANDING
Basic 12,471,928 11,989,473
Diluted 13,529,197 11,989,473
CONMED HEALTHCARE MANAGEMENT, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
For the Three For the Three
Months Ended Months Ended
March 31, 2009 March 31, 2008
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) $ 118,190 $ (552,054 )
Adjustments to reconcile net income to net
cash provided by operating activities
Depreciation 43,821 13,450
Amortization 591,000 486,000
Stock-based compensation 159,269 120,055
Change in fair value of derivatives (866 ) --
Changes in working capital components
(Increase) in accounts receivable (550,009 ) (686,526 )
Decrease in prepaid expenses 152,578 151,064
Decrease in deposits -- 45,000
Increase in accounts payable 272,945 260,191
Increase in accrued expenses 338,422 766,839
(Decrease) in income taxes payable (253,097 ) --
Increase (decrease) in deferred revenue 78,561 (164,038 )
Net cash provided by operating activities 950,814 439,981
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment (25,813 ) (186,301 )
Asset Purchase from EMDC, P.C. -- (245,711 )
Net cash used in investing activities (25,813 ) (432,012 )
CASH FLOWS FROM FINANCING ACTIVITIES
Payments on line of credit (100,000 ) --
Payments on loans (18,015 ) (1,901 )
Proceeds from exercise of warrants 6,000 --
Net cash provided by (used in) financing (112,015 ) (1,901 )
activities
Net increase in cash and cash equivalents 812,986 6,068
CASH AND CASH EQUIVALENTS
Beginning 7,472,140 7,136,720
Ending $ 8,285,126 $ 7,142,788
CONMED HEALTHCARE MANAGEMENT, INC.
RECONCILIATION OF PROFORMA GAAP NET LOSS FROM CONTINUING
OPERATIONS TO EARNINGS BEFORE INTEREST, TAXES,
DEPRECIATION AND AMORTIZATION (EBITDA) AND ADJUSTED EBITDA
Three Months Ended
March 31,
2009 2008
Net income (loss) $ 118,190 $ (552,054 )
Income tax expense 121,000 --
Interest income (28,628 ) (65,898 )
Interest expense 5,205 1,689
Depreciation and amortization 634,821 499,450
Earnings before interest, taxes, depreciation and 850,588 (116,813 )
amortization (EBITDA)
Stock based compensation 159,269 120,055
Change in fair value of derivatives (866 ) --
Adjusted EBITDA $ 1,008,991 $ 3,242
Source: Conmed Healthcare Management, Inc.
----------------------------------------------
Conmed Healthcare Management
Inc.
Thomas W. Fry
410-567-5529
Chief Financial Officer
tfry@conmed-inc.com
or
Hayden IR
Peter Seltzberg
646-415-8972
peter@haydenir.com
Register for real-time alerts, custom portfolio, and market movers
Penny Roger$
12 years ago
mlkrborn
12 years ago
Hot Features
Premium
